6-31864697-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_025257.3(SLC44A4):c.1966T>C(p.Phe656Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 32)
Consequence
SLC44A4
NM_025257.3 missense
NM_025257.3 missense
Scores
6
7
5
Clinical Significance
Conservation
PhyloP100: 8.87
Genes affected
SLC44A4 (HGNC:13941): (solute carrier family 44 member 4) The protein encoded by this gene may be a sodium-dependent transmembrane transport protein involved in the uptake of choline by cholinergic neurons. Defects in this gene can cause sialidosis, a lysosomal storage disease. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.881
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC44A4 | NM_025257.3 | c.1966T>C | p.Phe656Leu | missense_variant | 20/21 | ENST00000229729.11 | NP_079533.2 | |
SLC44A4 | NM_001178044.2 | c.1840T>C | p.Phe614Leu | missense_variant | 19/20 | NP_001171515.1 | ||
SLC44A4 | NM_001178045.2 | c.1738T>C | p.Phe580Leu | missense_variant | 20/21 | NP_001171516.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC44A4 | ENST00000229729.11 | c.1966T>C | p.Phe656Leu | missense_variant | 20/21 | 1 | NM_025257.3 | ENSP00000229729.6 | ||
SLC44A4 | ENST00000375562.8 | c.1840T>C | p.Phe614Leu | missense_variant | 19/20 | 2 | ENSP00000364712.4 | |||
SLC44A4 | ENST00000544672.5 | c.1738T>C | p.Phe580Leu | missense_variant | 20/21 | 2 | ENSP00000444109.1 | |||
SLC44A4 | ENST00000487680.1 | n.-17T>C | upstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 34
GnomAD4 exome
Cov.:
34
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 26, 2024 | The c.1966T>C (p.F656L) alteration is located in exon 20 (coding exon 20) of the SLC44A4 gene. This alteration results from a T to C substitution at nucleotide position 1966, causing the phenylalanine (F) at amino acid position 656 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;.;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
M_CAP
Benign
D
MetaRNN
Pathogenic
D;D;D;D
MetaSVM
Benign
T
MutationAssessor
Benign
L;.;.;.
PrimateAI
Pathogenic
T
PROVEAN
Pathogenic
D;D;D;.
REVEL
Uncertain
Sift
Uncertain
D;D;D;.
Sift4G
Uncertain
D;D;D;.
Polyphen
D;.;.;.
Vest4
MutPred
Loss of glycosylation at S653 (P = 0.08);.;.;.;
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at